Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

AstraZeneca discontinues ENTHUSE Study 15 of zibotentan in prostate cancer

Feb. 7, 2011

SHELTER trial data reported on resminostat in sorafenib-resistant hepatocellular carcinoma

Feb. 7, 2011

Armed oncolytic virus OBP-702 active against osteosarcoma cells

Feb. 7, 2011

PCI-27483/gemcitabine combination is safe in advanced/metastatic pancreatic cancer

Feb. 7, 2011

Regorafenib receives FDA orphan drug status in gastrointestinal stromal tumors

Feb. 4, 2011

New inhibitors of Mdm2/p53 interaction patented

Feb. 4, 2011

Apeiron acquires rights to hu14.18-IL2 from Merck KGaA

Feb. 4, 2011

FDA awards EGEN grant for phase II EGEN-001 development in ovarian cancer

Feb. 4, 2011

Marina Biotech and Debiopharm partner for RNAi-based bladder cancer therapy

Feb. 4, 2011

Smac mimetic JP-1201 enhances response to chemotherapy in models of pancreatic ductal carcinoma

Feb. 4, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...